5 Health Services Stocks Moving The Industry Upward

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 18 points (0.1%) at 15,482 as of Monday, July 15, 2013, 12:50 PM ET. The NYSE advances/declines ratio sits at 1,893 issues advancing vs. 1,042 declining with 108 unchanged.

The Health Services industry currently sits up 0.7% versus the S&P 500, which is up 0.1%. Top gainers within the industry include WellCare Health Plans ( WCG), up 3.3%, Centene Corporation ( CNC), up 1.6%, Cooper Companies ( COO), up 1.4%, CareFusion ( CFN), up 1.1% and Laboratory Corporation of America Holdings ( LH), up 0.8%. On the negative front, top decliners within the industry include MiMedx Group ( MDXG), down 8.1%, and Fresenius Medical Care AG & Co. KGaA ( FMS), down 0.7%.

TheStreet would like to highlight 5 stocks pushing the industry higher today:

5. Stryker Corporation ( SYK) is one of the companies pushing the Health Services industry higher today. As of noon trading, Stryker Corporation is up $0.49 (0.7%) to $67.92 on light volume. Thus far, 262,990 shares of Stryker Corporation exchanged hands as compared to its average daily volume of 1.4 million shares. The stock has ranged in price between $67.34-$67.96 after having opened the day at $67.41 as compared to the previous trading day's close of $67.43.

Stryker Corporation, a medical technology company, provides reconstructive, medical and surgical, and neurotechnology and spine products for doctors, hospitals, and other healthcare facilities. Stryker Corporation has a market cap of $25.5 billion and is part of the health care sector. Shares are up 22.9% year to date as of the close of trading on Friday. Currently there are 15 analysts that rate Stryker Corporation a buy, 1 analyst rates it a sell, and 12 rate it a hold.

TheStreet Ratings rates Stryker Corporation as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, solid stock price performance and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Stryker Corporation Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

These Stocks Are Ready to Reverse Course

Don't Get Out of Joint

Zimmer Biomet: Cramer's Top Takeaways

Market Stands at a Make-Or-Break Level: Cramer's 'Mad Money' Recap (Monday 7/17/17)

Analyst Says Rival Bidder Could Emerge for Novadaq After Stryker Deal